IMU Biosciences's $53M+: Decoding the Immune System at Scale
UK biotech IMU Biosciences extended its oversubscribed Series A past $53M in June 2026 to map and decode the human immune system for drug discovery.
Europe's venture capital market is maturing rapidly, with growing LP appetite for deep tech, defense, fintech, and sovereign AI capabilities. Our European VC coverage tracks fund formation, mega-rounds, and the policy and capital dynamics shaping the continent's startup ecosystem.
Browse European venture capital articles for regional funding insight.
UK biotech IMU Biosciences extended its oversubscribed Series A past $53M in June 2026 to map and decode the human immune system for drug discovery.
Stockholm AI startup Endra raised $50M Series A in June 2026 to automate design work for mechanical, electrical, and plumbing (MEP) consultants.
Primer raised $100M Series C from Sofina and Peak XV to scale AI-native payments — US ARR doubling YoY as autonomous finance ops go mainstream.
TechBBQ's August 26–27 Copenhagen program brings 1,700+ investors into one of Europe's most capital-efficient startup ecosystems.
London VC Week's May 11–15 program aggregates dozens of co-located VC events — an efficient alternative to traveling to three cities.
Latitude59's May 21–22 Tallinn event offers a near 1:1 founder-to-investor ratio — the best numerical efficiency in Europe.